Artemether-Lumefantrine versus Dihydroartemisinin-Piperaquine for Treating Uncomplicated Malaria: A Randomized Trial to Guide Policy in Uganda

BACKGROUND: Uganda recently adopted artemether-lumefantrine (AL) as the recommended first-line treatment for uncomplicated malaria. However, AL has several limitations, including a twice-daily dosing regimen, recommendation for administration with fatty food, and a high risk of reinfection soon afte...

Descripción completa

Detalles Bibliográficos
Autores principales: Yeka, Adoke, Dorsey, Grant, Kamya, Moses R., Talisuna, Ambrose, Lugemwa, Myers, Rwakimari, John Bosco, Staedke, Sarah G., Rosenthal, Philip J., Wabwire-Mangen, Fred, Bukirwa, Hasifa
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2405936/
https://www.ncbi.nlm.nih.gov/pubmed/18545692
http://dx.doi.org/10.1371/journal.pone.0002390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2405936/
https://www.ncbi.nlm.nih.gov/pubmed/18545692
http://dx.doi.org/10.1371/journal.pone.0002390

Ejemplares similares